Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Research Report 2023

Report ID: 1994952 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 CINV
        1.2.3 PONV
    1.3 Market by Application
        1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2018-2029)
    2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Region
        2.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Region (2018-2023)
        2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2024-2029)
    2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Dynamics
        2.3.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Trends
        2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
        2.3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
        2.3.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue
        3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2018-2023)
        3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2018-2023)
    3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
    3.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
        3.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2022
    3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
    3.6 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
    3.7 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Type
    4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2018-2023)
    4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2024-2029)
5 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Application
    5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Application (2018-2023)
    5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2018-2029)
    6.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023)
    6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2018-2029)
    7.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023)
    7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2018-2029)
    8.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2018-2029)
    9.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023)
    9.4 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2018-2029)
    10.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.1.5 Merck Recent Development
    11.2 Eisai
        11.2.1 Eisai Company Detail
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.2.5 Eisai Recent Development
    11.3 ProStrakan
        11.3.1 ProStrakan Company Detail
        11.3.2 ProStrakan Business Overview
        11.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.3.5 ProStrakan Recent Development
    11.4 Helsinn Holding
        11.4.1 Helsinn Holding Company Detail
        11.4.2 Helsinn Holding Business Overview
        11.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.4.5 Helsinn Holding Recent Development
    11.5 Mundipharma
        11.5.1 Mundipharma Company Detail
        11.5.2 Mundipharma Business Overview
        11.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.5.5 Mundipharma Recent Development
    11.6 Qilu Pharma
        11.6.1 Qilu Pharma Company Detail
        11.6.2 Qilu Pharma Business Overview
        11.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.6.5 Qilu Pharma Recent Development
    11.7 Teva
        11.7.1 Teva Company Detail
        11.7.2 Teva Business Overview
        11.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.7.5 Teva Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.8.5 Novartis Recent Development
    11.9 Heron Therapeutics
        11.9.1 Heron Therapeutics Company Detail
        11.9.2 Heron Therapeutics Business Overview
        11.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.9.5 Heron Therapeutics Recent Development
    11.10 Roche
        11.10.1 Roche Company Detail
        11.10.2 Roche Business Overview
        11.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.10.5 Roche Recent Development
    11.11 Mylan
        11.11.1 Mylan Company Detail
        11.11.2 Mylan Business Overview
        11.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.11.5 Mylan Recent Development
    11.12 Tesaro
        11.12.1 Tesaro Company Detail
        11.12.2 Tesaro Business Overview
        11.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
        11.12.5 Tesaro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of CINV
    Table 3. Key Players of PONV
    Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2018-2023)
    Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2024-2029)
    Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
    Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
    Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
    Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
    Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players (2018-2023)
    Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2022)
    Table 17. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
    Table 21. Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2018-2023)
    Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2024-2029)
    Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2018-2023)
    Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2024-2029)
    Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Merck Company Detail
    Table 47. Merck Business Overview
    Table 48. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 49. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 50. Merck Recent Development
    Table 51. Eisai Company Detail
    Table 52. Eisai Business Overview
    Table 53. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 54. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 55. Eisai Recent Development
    Table 56. ProStrakan Company Detail
    Table 57. ProStrakan Business Overview
    Table 58. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 59. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 60. ProStrakan Recent Development
    Table 61. Helsinn Holding Company Detail
    Table 62. Helsinn Holding Business Overview
    Table 63. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 64. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 65. Helsinn Holding Recent Development
    Table 66. Mundipharma Company Detail
    Table 67. Mundipharma Business Overview
    Table 68. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 69. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 70. Mundipharma Recent Development
    Table 71. Qilu Pharma Company Detail
    Table 72. Qilu Pharma Business Overview
    Table 73. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 74. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 75. Qilu Pharma Recent Development
    Table 76. Teva Company Detail
    Table 77. Teva Business Overview
    Table 78. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 79. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 80. Teva Recent Development
    Table 81. Novartis Company Detail
    Table 82. Novartis Business Overview
    Table 83. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 84. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 85. Novartis Recent Development
    Table 86. Heron Therapeutics Company Detail
    Table 87. Heron Therapeutics Business Overview
    Table 88. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 89. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 90. Heron Therapeutics Recent Development
    Table 91. Roche Company Detail
    Table 92. Roche Business Overview
    Table 93. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 94. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 95. Roche Recent Development
    Table 96. Mylan Company Detail
    Table 97. Mylan Business Overview
    Table 98. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 99. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 100. Mylan Recent Development
    Table 101. Tesaro Company Detail
    Table 102. Tesaro Business Overview
    Table 103. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 104. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023) & (US$ Million)
    Table 105. Tesaro Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2022 VS 2029
    Figure 3. CINV Features
    Figure 4. PONV Features
    Figure 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
    Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region: 2022 VS 2029
    Figure 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2022
    Figure 15. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2022
    Figure 17. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2018-2029)
    Figure 19. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2018-2029)
    Figure 23. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2018-2029)
    Figure 31. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2018-2029)
    Figure 39. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2018-2029)
    Figure 43. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 46. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 47. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 48. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 49. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 50. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 51. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 52. Novartis Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 53. Heron Therapeutics Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 54. Roche Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 55. Mylan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 56. Tesaro Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2018-2023)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Eisai
ProStrakan
Helsinn Holding
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Frequently Asked Questions
Chemotherapy-Induced Nausea and Vomiting (CINV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chemotherapy-Induced Nausea and Vomiting (CINV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chemotherapy-Induced Nausea and Vomiting (CINV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Closed Stopcocks

This report aims to provide a comprehensive presentation of the global market for Closed Stopcock ... Read More

High Flow Stopcocks

This report aims to provide a comprehensive presentation of the global market for High Flow Stopc ... Read More